United States

Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

16 Jul 2018
Change (% chg)

$-0.43 (-0.76%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small... (more)


Beta: 1.19
Market Cap(Mil.): $106,283.60
Shares Outstanding(Mil.): 1,639.93
Dividend: 0.39
Yield (%): 2.41


  BMY.N Industry Sector
P/E (TTM): 23.62 30.93 32.76
EPS (TTM): 2.74 -- --
ROI: 18.60 15.07 14.61
ROE: 30.97 16.60 16.34

Italy - Factors to watch on July 6

The following factors could affect Italian markets on Friday.

Jul 06 2018

Exclusive: BMS hires banks for 1 billion euro-plus sale of French OTC drug unit - sources

LONDON U.S. pharmaceuticals giant Bristol-Myers Squibb has hired two banks to find a buyer for its French over-the-counter (OTC) drugs business, which could be valued at more than 1 billion euros in a potential deal, sources familiar with the matter told Reuters.

Jul 05 2018

Australia shares end down, commodities drag; NZ finishes at record

* Commodity stocks lead losses, banks rise as CBA extends gains

Jun 05 2018

The next battleground after SCOTUS' BMS ruling? Class actions, defense lawyers say

Product liability defense lawyers expect the U.S. Supreme Court to eventually look at making explicit that the restrictions it placed on where plaintiffs can bring injury claims in Bristol-Myers Squibb v. Superior Court of California also apply to class actions.

Jun 04 2018

Tech rally helps Wall Street push higher, Nasdaq has record close

NEW YORK Wall Street's three major indexes rose on Monday, led by a rally in tech stocks, pushing the Nasdaq to a record closing high as investors bet on a continuation of strong economic growth, while falling oil prices weighed on the energy sector. | Video

Jun 04 2018

US STOCKS-Tech rally helps Wall St push higher, Nasdaq has record close

* Indexes gain: Dow 0.72 pct, S&P 0.45 pct, Nasdaq 0.69 pct (Updates to close, adds commentary)

Jun 04 2018

US STOCKS-Technology rally helps Wall Street push higher

* Indexes gain: Dow 0.66 pct, S&P 0.41 pct, Nasdaq 0.57 pct (Updates to late afternoon, adds commentary, changes byline, adds New York dateline)

Jun 04 2018

US STOCKS-Tech rally fuels Nasdaq to near record levels

* Indexes gain: Dow 0.76 pct, S&P 0.42 pct, Nasdaq 0.59 pct (Changes comment, adds details, updates prices)

Jun 04 2018

US STOCKS-Wall Street higher as Apple leads tech rally

* Indexes gain: Dow 0.73 pct, S&P 0.27 pct, Nasdaq 0.28 pct (Changes comment, adds details, updates prices)

Jun 04 2018

Mixed results for Bristol/Nektar combination in cancer trial

Chicago, June 3 Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co's cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led at least one Wall Street analyst to reassess expectations.

Jun 03 2018


  Price Chg
Johnson & Johnson (JNJ.N) $124.69 -1.24
Pfizer Inc. (PFE.N) $37.38 -0.15
Merck & Co., Inc. (MRK.N) $62.59 -0.30
Sanofi SA (SASY.PA) €70.95 -0.71
AstraZeneca plc (AZN.L) 5,490.00 +23.00
GlaxoSmithKline plc (GSK.L) 1,556.80 -1.40
Eli Lilly And Co (LLY.N) $89.07 -0.64
Roche Holding Ltd. (ROG.S) CHF229.95 -2.30
Roche Holding Ltd. (RO.S) CHF234.20 -2.40

Earnings vs. Estimates